A Clinical Trial to Evaluate Tegavivint in Pediatric Cancers
Latest Information Update: 22 Feb 2021
At a glance
- Drugs Tegavivint (Primary)
- Indications Lymphoma; Sarcoma; Solid tumours
- Focus Adverse reactions
- Sponsors Iterion Therapeutics
Most Recent Events
- 22 Feb 2021 New trial record